Fecha de actualización: Septiembre de 2018

 

Discovery
Click for more info Project Teaser


Indication
Target
CM-352 Bleeding
Disorders
Research Group
MMP10 & MMP3

 

CM-272 Cancer
AML & HCC
Research Group
DNMT & G9a

 

CM-414 Alzheimer’s Disease
Research Group
PDE5 & HDACs

 

CM-1315 Onco-immunology

Research Group

Disruption of FOXP3 dimerization

 

Apo-Insulin

Diabetes

Research Group

Insulin
Receptor

 

Sushi-IL15-
Apo
Onco-immunology
Research Group
Receptor
IL-15

 

CM-1349 Acute
intermittent porphyria
Research Group
PBGD

 

CIRP-vaccine Onco-immunology
Research Group
CD8 T cell simulation

 

Eliratra Onco-immunology

Research Group

Immune response

 

Apo-
FGF19
Liver
regeneration
Research Group
FGF19 receptor

 

Target ID In vitro
Assays
Hit ID In vivo PoC
/ Lead id
ADMET / PK
Optimización
Preclinical Clinical
 
   
   
   
     
     
     
     
     
     
IP


ok
ok
ok
ok
ok
ok
ok
ok
ok
ok
 


 

Early Discovery
Click for more info Project Teaser


Indication
Target
CM-166 Heart Failure fibrosis

Research Group

Novel Target (undisclosed)

 

Viro Therapy Onco-immunology
Research Group

Inmune response

 

CM-1351 Onco-immunologyResearch Group

Disruption Foxp3/ NFAT interaction

 

GPCR-X antagonist Alzheimers's Disease
Research Group
Novel Target (GPCR-undisclosed)

 

CM-3132 Dravet Syndrome
Research Group
SCN1A

 

Target ID In vitro
Assays
Hit ID In vivo PoC
/ Lead id
ADMET / PK
Optimización
Preclinical Clinical
   
   
     
     
     
Partners
IP

Undisclosed in-process
   
Undisclosed in-process
ok in-process
  in-process
 


 

Licensed Products in PreClinical & Clinical Phases
Click for more info Project Teaser


Indication
CardioPatch Heart Failure

Research Group

EDA vaccine Cervical
Cancer

Research Group

a5-IFN Manufacturing
rh-CT 1 * Acute kidney injure
AAV-PBGD * Acute intermittent Porphyria
CM-144 * Scleroderma

 

R&D Preclinical
Phase I Phase II Phase III
     
     
 
 
 
 
Licensed
IP


Viscofan ok
Formune ok
BioTechpharma ok
Digna Biotech ok
Uniqure ok
Digna Biotech ok

 

* Terminated


 

Diagnostics

Click for more info Project Teaser


Indication
C4 activation fragment Lung Cancer

Research Group

BM Panel Heart Failure

Research Group

ADC Pronostic Index Lung adenocarcinoma

Research Group

SCC Pronostic Index Lung squamous cells carcinoma

Research Group

Biomarker
identification
Analytical
Validation
Retrospective Clinical
Validation
Protrospective Clinical
Validation
Regulation
Process
Clinical
Utility
   
   
       
       
Partners
Licensed
IP


ok   ok
     
    ok
    ok